The price-to-earnings ratio for Inmode Ltd (NASDAQ: INMD) is above average at 8.77x, Company’s 36-month beta value is 2.20.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for INMD is 75.25M, and currently, short sellers hold a 9.05% ratio of that floaft. The average trading volume of INMD on June 05, 2024 was 1.27M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
INMD) stock’s latest price update
Inmode Ltd (NASDAQ: INMD)’s stock price has decreased by -1.65 compared to its previous closing price of 18.82. However, the company has seen a -1.33% decrease in its stock price over the last five trading sessions. prnewswire.com reported 2024-05-16 that YOKNEAM, Israel, May 16, 2024 /PRNewswire/ — InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present in-person at the Jefferies Healthcare Conference in New York on June 5, 2024.
INMD’s Market Performance
Inmode Ltd (INMD) has seen a -1.33% fall in stock performance for the week, with a -0.75% decline in the past month and a -18.67% plunge in the past quarter. The volatility ratio for the week is 2.70%, and the volatility levels for the past 30 days are at 2.72% for INMD. The simple moving average for the last 20 days is -1.15% for INMD stock, with a simple moving average of -21.33% for the last 200 days.
Analysts’ Opinion of INMD
Many brokerage firms have already submitted their reports for INMD stocks, with UBS repeating the rating for INMD by listing it as a “Neutral.” The predicted price for INMD in the upcoming period, according to UBS is $24 based on the research report published on November 03, 2023 of the previous year 2023.
Canaccord Genuity, on the other hand, stated in their research note that they expect to see INMD reach a price target of $22, previously predicting the price at $55. The rating they have provided for INMD stocks is “Hold” according to the report published on October 13th, 2023.
UBS gave a rating of “Buy” to INMD, setting the target price at $40 in the report published on March 29th of the previous year.
INMD Trading at -0.74% from the 50-Day Moving Average
After a stumble in the market that brought INMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.64% of loss for the given period.
Volatility was left at 2.72%, however, over the last 30 days, the volatility rate increased by 2.70%. Over the last 50 days, in opposition, the stock is trading -9.54% lower at present.
During the last 5 trading sessions, INMD fell by -1.39%, which changed the moving average for the period of 200-days by -50.61% in comparison to the 20-day moving average, which settled at $18.73. In addition, Inmode Ltd saw -16.77% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for INMD
Current profitability levels for the company are sitting at:
- 0.37 for the present operating margin
- 0.83 for the gross margin
The net margin for Inmode Ltd stands at 0.39. The total capital return value is set at 0.21. Equity return is now at value 25.54, with 23.20 for asset returns.
Based on Inmode Ltd (INMD), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 28.94.
Currently, EBITDA for the company is 196.28 million with net debt to EBITDA at -0.66. When we switch over and look at the enterprise to sales, we see a ratio of 3.13. The receivables turnover for the company is 8.96for trailing twelve months and the total asset turnover is 0.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.45.
Conclusion
In a nutshell, Inmode Ltd (INMD) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
